GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
基因型
基本信息
- 批准号:6441967
- 负责人:
- 金额:$ 2.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-12-01 至 2001-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a pilot study looking at three disease genes for Leber Congenital Amaurosis, early onset Retinitis Pigmentosia (RP) and Cone-Rod Dystrophy (CRD), and the likelihood that these genes govern human retinal functions that can be evaluated by appropriate tests. The three genes are CRX, which is involved in opsin expression and photoreceptor differentiation; expressed in the photoreceptor; RetGC, Retinal Guanylyl Cyclase; also expressed in the photoreceptors; RPE65, expressed in the retinal pigment epithelium, possibly the isomerase in the visual cycle. Mutations of CRX are predicted to cause deficient opsin expression with consequent deficiencies in the visual pigment rhodopsin, shortening of the photorecptor outer segments, low photocurrent, reductions in the photoreceptor and visual sensitivity that are proportional to the amount of the visual pigment present. These predictions can be tested with a combination of electroretinographic and psychophysical procedures, such as measurements of threshold during dark adaptation. The protein of RetGC is guanylyl cyclase. Cyclic GMP channels in the photoreceptor outer segments are open in the dark, and close in response to light. The cyclase resynthesizes cGMP. The investigators predict abnormalities in the cyclase will alter the kinetics of recovery of the photoreceptors' photocurrent with consequent alterations in retinal adaptation, that is the adjustment to light and dark. This can be tested by studies of dark adaptation and ERG assessment of the kinetics of recovery of the photoreceptors' response to light. RPE65 is expressed in the pigment epithelium, and is involved in metabolism of retinoids. Possibly the protein is the isomerase in the visual cycle. This enzyme converts all trans to the 11-cis form of retinaldehyde which is bound to opsin to form the visual pigment in the photoreceptor outer segments. The visual pigment catches light and starts the processes that result in vision. The investigators hypothesize that RPE65, by alterations in isomerase (or closely related enzymes), alter the kinetics of recovery of the photoreceptor's sensitivity and visual sensitivity after exposure to light. This prediction can be tested by using a combination of tests of vision and retinal function that employ electroretinographic and psychophysical procedures. The above hypotheses will be tested in individuals who are obligate heterozygotes for LCA and the related conditions. These individuals are the parents of affected children. The affected children have severe visual impairment and nystagmus which limits the possibility of testing the hypotheses in them.
这是一项初步研究,着眼于莱伯先天性黑蒙、早发性视网膜色素变性(RP)和视锥细胞营养不良(CRD)的三种疾病基因,以及这些基因控制人类视网膜功能的可能性,可以通过适当的测试进行评估。这三个基因分别是CRX,参与视蛋白表达和光感受器分化;在光感受器中表达; RetGC,视网膜鸟苷酸环化酶;也在光感受器中表达; RPE65,在视网膜色素上皮中表达,可能是视觉循环中的异构酶。预计 CRX 突变会导致视蛋白表达缺陷,从而导致视色素视紫红质缺陷、感光器外节缩短、光电流降低、光感受器和视觉敏感度降低(与视色素存在量成正比)。这些预测可以通过结合视网膜电图和心理物理学程序来测试,例如暗适应过程中阈值的测量。 RetGC的蛋白质是鸟苷酸环化酶。光感受器外节中的环状 GMP 通道在黑暗中打开,并在光线响应时关闭。环化酶重新合成 cGMP。研究人员预测环化酶的异常将改变光感受器光电流恢复的动力学,从而改变视网膜适应,即对光和暗的调整。这可以通过暗适应研究和光感受器光响应恢复动力学的 ERG 评估来测试。 RPE65 在色素上皮中表达,并参与类视黄醇的代谢。该蛋白质可能是视觉循环中的异构酶。这种酶将所有反式视黄醛转化为 11-顺式视黄醛,视黄醛与视蛋白结合,在感光器外节中形成视色素。视觉色素捕捉光线并启动产生视觉的过程。研究人员推测,RPE65 通过异构酶(或密切相关的酶)的改变,改变暴露于光后感光器敏感性和视觉敏感性恢复的动力学。这种预测可以通过结合使用视网膜电图和心理物理程序的视力和视网膜功能测试来进行测试。上述假设将在 LCA 和相关病症的专性杂合子个体中进行检验。这些人是受影响儿童的父母。受影响的儿童有严重的视力障碍和眼球震颤,这限制了测试他们的假设的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE B FULTON其他文献
ANNE B FULTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE B FULTON', 18)}}的其他基金
Adaptive Optics Imager for Study of Pediatric Retinal Disorders
用于研究儿童视网膜疾病的自适应光学成像仪
- 批准号:
7595302 - 财政年份:2009
- 资助金额:
$ 2.88万 - 项目类别:
A SYSTEM FOR STUDY OF PEDIATRIC VISUAL PATHWAYS: EYE
研究儿童视觉通路的系统:眼睛
- 批准号:
6973582 - 财政年份:2004
- 资助金额:
$ 2.88万 - 项目类别:
A SYSTEM FOR STUDY OF PEDIATRIC VISUAL PATHWAYS: NEUROSCIENCE
儿科视觉通路研究系统:神经科学
- 批准号:
6973583 - 财政年份:2004
- 资助金额:
$ 2.88万 - 项目类别:
Retcam 120 Wide Field Digital Imaging System
Retcam 120 广角数字成像系统
- 批准号:
6440432 - 财政年份:2002
- 资助金额:
$ 2.88万 - 项目类别:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
基因型
- 批准号:
6568561 - 财政年份:2001
- 资助金额:
$ 2.88万 - 项目类别:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
基因型
- 批准号:
6485566 - 财政年份:2000
- 资助金额:
$ 2.88万 - 项目类别:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
基因型
- 批准号:
6308974 - 财政年份:1999
- 资助金额:
$ 2.88万 - 项目类别:
GENOTYPE & PHENOTYPE IN LEBER CONGENITAL AMAUROSIS & RELATED RETINAL DISORDERS
基因型
- 批准号:
6265648 - 财政年份:1998
- 资助金额:
$ 2.88万 - 项目类别:
PHOTORECEPTOR FUNCTION IN RETINOPATHY OF PREMATURITY
早产儿视网膜病变中的光感受器功能
- 批准号:
6518524 - 财政年份:1994
- 资助金额:
$ 2.88万 - 项目类别:
相似国自然基金
周边与中央视觉拥挤效应的心理物理学与脑机制研究及临床应用
- 批准号:32371097
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MicroRNA-23a/HMGN2通过染色质重塑调控中性粒细胞抗细菌免疫的作用机制及其临床检测价值研究
- 批准号:82302630
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
联合脑电和眼动信号的多模态情绪识别脑机接口及其临床应用研究
- 批准号:62306120
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
临床药物麝香酮调控基因回路的设计、构建及其用于非酒精性脂肪性肝炎的基因治疗研究
- 批准号:32301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the mechanism of erythropoietin (EPO) in mitigating Dry-AMD pathophysiology
阐明促红细胞生成素 (EPO) 缓解干性 AMD 病理生理学的机制
- 批准号:
10521937 - 财政年份:2022
- 资助金额:
$ 2.88万 - 项目类别:
Role of Macrophages in Age-Related Macular Degeneration
巨噬细胞在年龄相关性黄斑变性中的作用
- 批准号:
10463562 - 财政年份:2020
- 资助金额:
$ 2.88万 - 项目类别:
Role of Macrophages in Age-Related Macular Degeneration
巨噬细胞在年龄相关性黄斑变性中的作用
- 批准号:
10012438 - 财政年份:2020
- 资助金额:
$ 2.88万 - 项目类别:
Role of Macrophages in Age-Related Macular Degeneration
巨噬细胞在年龄相关性黄斑变性中的作用
- 批准号:
10217055 - 财政年份:2020
- 资助金额:
$ 2.88万 - 项目类别:
Role of Macrophages in Age-Related Macular Degeneration
巨噬细胞在年龄相关性黄斑变性中的作用
- 批准号:
10795633 - 财政年份:2020
- 资助金额:
$ 2.88万 - 项目类别: